ROWASA 500 mg, suppository 15 suppositories
Active ingredients: Mesalazine
Commercialized according to BDPMDispensing in France: Prescription only
Suppository15 suppositoriesrectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROWASA 500 mg, suppositoire
- Pharmaceutical form
- suppositoire
- Route of administration
- rectale
- Presentation description
- plaquette(s) thermoformée(s) polyéthylène PVC de 15 suppositoire(s)
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1993
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64352822CIP73350367CIP133400933503673Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSALAZINEsuppositoire | 500 mg · un suppositoire | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.